Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
A microRNA-21 surge facilitates rapid cyclin D1 translation and cell cycle progression in mouse liver regeneration
Raymond Ng, … , Niels M. Frandsen, Holger Willenbring
Raymond Ng, … , Niels M. Frandsen, Holger Willenbring
Published February 13, 2012
Citation Information: J Clin Invest. 2012;122(3):1097-1108. https://doi.org/10.1172/JCI46039.
View: Text | PDF
Research Article Hepatology

A microRNA-21 surge facilitates rapid cyclin D1 translation and cell cycle progression in mouse liver regeneration

  • Text
  • PDF
Abstract

MicroRNA-21 (miR-21) is thought to be an oncomir because it promotes cancer cell proliferation, migration, and survival. miR-21 is also expressed in normal cells, but its physiological role is poorly understood. Recently, it has been found that miR-21 expression is rapidly induced in rodent hepatocytes during liver regeneration after two-thirds partial hepatectomy (2/3 PH). Here, we investigated the function of miR-21 in regenerating mouse hepatocytes by inhibiting it with an antisense oligonucleotide. To maintain normal hepatocyte viability and function, we antagonized the miR-21 surge induced by 2/3 PH while preserving baseline expression. We found that knockdown of miR-21 impaired progression of hepatocytes into S phase of the cell cycle, mainly through a decrease in levels of cyclin D1 protein, but not Ccnd1 mRNA. Mechanistically, we discovered that increased miR-21 expression facilitated cyclin D1 translation in the early phase of liver regeneration by relieving Akt1/mTOR complex 1 signaling (and thus eIF-4F–mediated translation initiation) from suppression by Rhob. Our findings reveal that miR-21 enables rapid hepatocyte proliferation during liver regeneration by accelerating cyclin D1 translation.

Authors

Raymond Ng, Guisheng Song, Garrett R. Roll, Niels M. Frandsen, Holger Willenbring

×

Figure 4

Inhibition of miR-21 delays S phase entry of hepatocytes after 2/3 PH.

Options: View larger image (or click on image) Download as PowerPoint
Inhibition of miR-21 delays S phase entry of hepatocytes after 2/3 PH.
(...
(A and B) Quantification of Ki67 and PCNA immunostainings (both brown) showed that many hepatocytes had entered S phase at 36 hours after 2/3 PH in control mice. Significantly fewer hepatocytes stained positive for these markers or cyclin D1 (all brown) in mice injected with miR-21–ASO. For each immunostaining, approximately 1,500 hepatocytes (250 per frame) were analyzed per time point and treatment. Original magnification, ×200. (C) Immunoblotting showed lower cyclin D1 protein levels at 36 hours after 2/3 PH in livers of mice injected with miR-21–ASO compared with controls. Numbers indicate protein levels relative to time point 0 hours after 2/3 PH. Gapdh was analyzed as a loading control. (D) qRT-PCR showed that miR-21–ASO injection did not interfere with induction of liver Ccnd1 transcription at 36 hours after 2/3 PH. At least 3 mice were analyzed for each time point and treatment. miR-21–ASO was injected at 6 hours after 2/3 PH. Control mice were injected with carrier at 6 hours after 2/3 PH. Data represent mean ± SEM. *P < 0.05, **P < 0.01.
Follow JCI:
Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts